Related Experiment Video
Updated: May 28, 2026

Isolation of Regenerating Hepatocytes after Partial Hepatectomy in Mice
Published on: December 2, 2022
Biochemical liver function after partial hepatic resection with or without partial hepatic vascular exclusion.
Orlando Castro e Silva1, Enio David Mente, Ajith Kumar Sankarankutty
1Division of Digestive Surgery, FMRP, USP, Ribeirao Preto, Sao Paulo, Brazil. orlando@fmrp.usp.br
Liver vascular partial exclusion (LVPE) is a safe technique during liver resection. This study found LVPE does not negatively impact mitochondrial function or increase liver enzyme levels post-surgery.
Area of Science:
- Hepatobiliary Surgery
- Surgical Oncology
- Transplant Surgery
Background:
- Liver resection is a common procedure for hepatic malignancies.
- Minimizing ischemia-reperfusion injury is crucial for preserving remnant liver function.
- Liver vascular partial exclusion (LVPE) is a technique used to reduce blood flow during liver resection.
Purpose of the Study:
- To evaluate the safety and impact of liver vascular partial exclusion (LVPE) during partial hepatectomy.
- To assess the advantages and disadvantages of LVPE concerning liver dysfunction due to ischemia.
Main Methods:
- A comparative study involving 114 patients undergoing partial hepatectomy.
- 57 patients underwent LVPE, while 57 served as a control group.
- Mitochondrial function and serum aminotransferases were measured post-surgery.
Main Results:
- No significant differences in mitochondrial function were observed between minor and major liver resections.
- Postoperative peak aminotransferase levels were similar in patients with and without LVPE.
Conclusions:
- LVPE did not induce mitochondrial dysfunction in hepatic tissue.
- Aminotransferase levels remained comparable, indicating LVPE is safe.
- LVPE does not cause significant ischemia-reperfusion injury in the liver remnant.
Related Concept Videos
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test
Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow

